Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Channel Rhodopsins01:11

Channel Rhodopsins

Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional asymmetry and essential structural roles of PDE6α and PDE6β subunits in rod-photoreceptor integrity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A combinatorial synthetic strategy for developing genome-editing protein-delivery agents targeting mouse retina.

Nature communications·2026
Same author

Age-Driven Lipid Remodeling Activates Lysosome-Mediated Plasma Membrane Repair.

Research square·2026
Same author

Structural analysis of rhodopsin states in megabody complexes.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

TIGER: A tdTomato in vivo genome-editing reporter mouse for investigating precision-editor delivery approaches.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Rationally Designed, Short-Acting RPE65 Inhibitors for Visual Cycle-Associated Retinopathies.

Journal of medicinal chemistry·2025
Same journal

A Lithium Superionic Conductor Softened by Nonmetal-Chlorine Chemical Bonds.

Journal of the American Chemical Society·2026
Same journal

A Ferrocene Metal-Ligand Triplet Diradical with a Terminal Iminyl Group Discovered by Time-Resolved Mid-Infrared Spectroscopy.

Journal of the American Chemical Society·2026
Same journal

Regulating Li-Ion Transport via Solvent and Ion Clustering Using Ternary Salts in Nonfluorinated Solvents for Extended Cyclability of Zero-Excess Lithium-Metal Batteries.

Journal of the American Chemical Society·2026
Same journal

Terahertz-Field-Induced Dissociation of Frenkel Excitons in Organic Semiconductors.

Journal of the American Chemical Society·2026
Same journal

Interplay between Slow Chirality Inversion and Slow Guest Uptake in a Triple-Helical Closed-Cage Metallocryptand.

Journal of the American Chemical Society·2026
Same journal

Controlled Sulfane Sulfur Delivery via Allyl Disulfide Rearrangement-Mediated Thiosulfoxide Formation.

Journal of the American Chemical Society·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation
08:00

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation

Published on: October 4, 2024

Light-Activated RPE65 Inhibitors Enable On-Demand Visual Cycle Control.

Marco Bassetto1,2,3, Bowen Li4, Xiuyuan Chen4

  • 1Department of Physiology and Biophysics, University of California, Irvine, Irvine, California 92697, United States.

Journal of the American Chemical Society
|May 19, 2026
PubMed
Summary
This summary is machine-generated.

New light-activated therapies use photoswitchable visual cycle modulators (VCMs) to treat blinding diseases. This approach allows on-demand drug delivery, reducing side effects like night blindness and protecting retinal health.

More Related Videos

Direct-Coupled Electroretinogram (DC-ERG) for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium
09:10

Direct-Coupled Electroretinogram (DC-ERG) for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium

Published on: July 14, 2020

Selective Viral Transduction of Adult-born Olfactory Neurons for Chronic in vivo Optogenetic Stimulation
12:00

Selective Viral Transduction of Adult-born Olfactory Neurons for Chronic in vivo Optogenetic Stimulation

Published on: December 28, 2011

Related Experiment Videos

Last Updated: May 21, 2026

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation
08:00

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation

Published on: October 4, 2024

Direct-Coupled Electroretinogram (DC-ERG) for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium
09:10

Direct-Coupled Electroretinogram (DC-ERG) for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium

Published on: July 14, 2020

Selective Viral Transduction of Adult-born Olfactory Neurons for Chronic in vivo Optogenetic Stimulation
12:00

Selective Viral Transduction of Adult-born Olfactory Neurons for Chronic in vivo Optogenetic Stimulation

Published on: December 28, 2011

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Biochemistry

Background:

  • Light is crucial for vision but can worsen blinding diseases linked to the visual (retinoid) cycle.
  • Current visual cycle modulators (VCMs) cause side effects like night blindness due to chronic suppression.

Purpose of the Study:

  • To develop novel VCMs activated by visible light through Z→E photoisomerization.
  • To create light-inducible VCMs for targeted, on-demand inhibition of the visual cycle.

Main Methods:

  • Synthesized azobenzene-containing VCMs, including (Z)-9.
  • Investigated the photoisomerization of (Z)-9 to its active E-configuration using visible light.
  • Assessed the efficacy of (E)-9 in protecting the retina from toxicity and its pharmacodynamic duration compared to emixustat via electroretinography.

Main Results:

  • (Z)-9, a weak RPE65 inhibitor, becomes potent upon light-activated Z→E isomerization.
  • (E)-9 demonstrated retinal protection against visual cycle toxicity.
  • Oral administration of (E)-9 exhibited a shorter duration of action than emixustat.

Conclusions:

  • Established posterior-segment photopharmacology using light-activated VCMs.
  • Developed a blueprint for therapies mitigating daytime toxicity while preserving night vision.
  • Demonstrated the potential of light-activated VCMs for safer, more effective treatment of blinding retinopathies.